Dr. Fehling’s approach to medicine is grounded in the belief that healthcare should not start when disease appears, but years or decades earlier.
Rather than focusing solely on symptoms, her work centers on identifying underlying risk factors, understanding individual biology, and addressing health proactively. This philosophy aligns with the principles of Medicine 3.0, combining evidence-based diagnostics, long-term prevention strategies, and patient education to support sustained health and resilience over time.
A particular focus of her work is addressing long-standing gaps in women’s healthcare, where conditions are often underdiagnosed, normalized, or treated too late.
Dr. Fehling’s clinical and strategic work focuses on:
Her work emphasizes individualized care, data-informed decision-making, and long-term outcomes rather than short-term symptom management.
Dr. Maya Fehling trained as a physician at LMU Munich and holds a Master of International Health from Charité, Universitätsmedizin Berlin. She is a Harvard Global Health Leadership Fellow and completed an MBA at ESMT Berlin, combining clinical medicine with expertise in global health systems, leadership, and health innovation.
Following her medical training, Dr. Fehling worked clinically in Europe and the United States, as well as internationally in humanitarian settings with organizations such as Doctors Without Borders. These experiences provided her with a deep understanding of both individual patient care and the broader structural challenges of healthcare systems.
Through this experience, she gained deep insight into both the strengths and limitations of conventional healthcare systems, particularly their reactive nature and the lack of long-term, preventive strategies, especially for women.
Motivated by these observations, Dr. Fehling transitioned into the innovative health space, working with startups developing solutions in female health, prevention, menopause, and sexual health. Her work has consistently focused on overcoming stigma, improving access to evidence-based care, and translating medical science into practical, patient-centered solutions.
As Co-Founder and Chief Medical Officer of The Longevity Practice, Dr. Fehling is responsible for:
She plays a central role in shaping the clinic’s long-term vision and its commitment to modern, evidence-based longevity medicine.
Dr. Fehling regularly contributes to the public conversation on female health, longevity, and preventive medicine through podcasts, media interviews, and thought pieces.
Examples include:
